Immunotherapy for Infectious Diseases

Active Immunization for HIV Infection 197
123. Tubiana R, Gomard E, Fleury H, et al. Vaccine therapy in early HIV-1 infection using a
recombinant canarypox virus expressing gp160MN (ALVAC-HIV): a double-blind controlled
randomized study of safety and immunogenicity [letter]. AIDS 1997; 11:819.
124. Dhodapkar MV, Krasovsky J, Steinman RM, Bhardwaj N. Mature dendritic cells boost
functionally superior CD8(�) T-cell in humans without foreign helper epitopes. J Clin
Invest 2000; 105:R9.
125. Dhodapkar MV, Steinman RM, Sapp M, et al. Rapid generation of broad T-cell immunity
in humans after a single injection of mature dendritic cells. J Clin Invest 1999; 104:173.
126. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N. Antigen-specific inhibition
of effector T cell function in humans after injection of immature dendritic cells.
J Exp Med 2001; 193:233.
127. Engelmayer J, Larsson M, Lee A, et al. Mature dendritic cells infected with canarypox
virus elicit strong anti-human immunodeficiency virus CD8� and CD4� T-cell responses
from chronically infected individuals. J Virol 2001; 75:2142.
128. Caley IJ, Betts MR, Irlbeck DM, et al. Humoral, mucosal, and cellular immunity in
response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan
equine encephalitis virus vaccine vector. J Virol 1997; 71:3031.
129. Davis NL, Caley IJ, Brown KW, et al. Vaccination of macaques against pathogenic simian
immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.
[erratum appears in J Virol 2000;74:3430]. J Virol 2000; 74:371.
130. Egan MA, Charini WA, Kuroda MJ, et al. Simian immunodeficiency virus (SIV) gag
DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses
and control viral replication after pathogenic SIV infection. J Virol 2000; 74:7485.
131. Lu S, Arthos J, Montefiori DC, et al. Simian immunodeficiency virus DNA vaccine trial
in macaques. J Virol 1996; 70:3978.
132. Barouch DH, Santra S, Schmitz JE, et al. Control of viremia and prevention of clinical
AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 2000;
290:486.
133. Amara RR, Villinger F, Altman JD, et al. Control of a mucosal challenge and prevention
of AIDS by a multiprotein DNA/MVA vaccine. Science 2001; 292:69.
134. Buge SL, Murty L, Arora K, et al. Factors associated with slow disease progression in
macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope
priming-gp120 boosting regimen and challenged vaginally with SIVmac251. J Virol 1999;
73:7430.
135. Allen TM, O’Connor DH, Jing P, et al. Tat-specific cytotoxic T lymphocytes select for
SIV escape variants during resolution of primary viraemia. Nature 2000; 407:386.